Back

Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on carotid intima-media thickness

2 September 2024 (15:00 - 15:40)
Organised by: Logo
Congress Presentation Part of: Carotid plaque: epidemiology and evolution Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Konstantinos Katogiannis

Attikon University Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Plasma cytokines are associated with major adverse cardiovascular events in follow-up of patients undergoing carotid endarterectomy
Doctor V. Nardi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Adverse outcomes following carotid artery stenting in echolucent plaques: a systematic review and meta-analysis
Associate Professor P. Ibrahimi (Pristina, XK)
Abstract Slides Video
Presentation thumbnail
Plasma levels of sCASP3 predicts carotid intima media thickness progression
Miss M. Pan (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Mortality risk in patients with carotid artery disease undergoing carotid endarterectomy compared to the general population
Doctor L. Di Venanzio (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Minimal extra-cardiac atherosclerosis in people <50 years with sudden cardiac death due to coronary disease
Doctor E. Paratz (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Carotid plaque: epidemiology and evolution

The Event

Event poster

ESC Congress 2024

2 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of a 12-month treatment with liraglutide, empagliflozin and their combination on carotid intima-media thickness in patients with type 2 diabetes mellitus
30 August 2025
thumbnail
Congress Presentation
Cardiometabolic benefits of dual GLP1-RA and SGLT2i therapy in patients with HFpEF, T2DM, obesity, and obstructive sleep apnea: a prospective study
29 August 2025
thumbnail
Congress Presentation
GLP1 receptor agonists and CAD regression in diabetic patients after ACS
31 August 2025
thumbnail
Congress Presentation
Twelve-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources